Arthroscopic-assisted scapho-trapezio-trapezoeid arthrodesis for the treatment of Kienb?ck disease

雷高炜,冯俊涛,尹华伟,沈云东,徐文东
DOI: https://doi.org/10.3760/cma.j.cn311653-20191122-06343
2020-01-01
Abstract:Objective:To investigate the clinical efficacy of arthroscopic-assisted scapho-trapezio-trapezoeid (STT) arthrodesis for the treatment of the Lichtman Ⅲb stage Kienb?ck disease.Methods:From February 2013 to March 2016, 11 patients diagnosed as Lichtman Ⅲb stage Kienb?ck disease were treated by arthroscopic-assisted STT arthrodesis. The range of motion and grip strength of the wrist were measured before and after the operation, and the wrist PRWE and the modified Mayo wrist score were performed. The curative effect was evaluated according to the X-ray examination results before and after operation.Results:All the 11 patients were follow-up for 13 to 91 months, with an average of 40.8 months. The average score of VAS was (6.45±0.58) before operation and (1.90±0.37) after operation. The difference was statistically significant ( P<0.05). The wrist pain was relieved after operation. The average grip strength before operation was (8.53±1.83) kg, and after operation was (14.48±2.38) kg; the wrist PRWE score before operation was 74.86±2.13, and after operation was 21.46±4.57; the modified Mayo wrist score before operation was 31.36±2.53, and after operation was 70.91±3.22. The differences were statistically significant ( P<0.05), and the wrist grip strength and function score after operation were significantly improved. The results of long-term X-ray showed that there was no obvious aggravation after the operation. Conclusion:The application of arthroscopic-assisted STT arthrodesis for the treatment of Lichtman Ⅲb stage Kienb?ck disease can relieve the pain, improve the function of wrist joint, prevent the collapse of the lunate and the progression of the disease, but not improve the active motion of wrist joint.
What problem does this paper attempt to address?